Jose L. Ventura-Martin

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Immunoglobulin A/PIGR axis as potential mediators of human abdominal aortic aneurysms revealed by topologically resolved proteomics.

Immunoglobulin A/PIGR axis as potential mediators of human abdominal aortic aneurysms revealed by topologically resolved proteomics.

Journal: Journal of translational medicine

Published: October 16, 2024

B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease.

B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease.

Journal: Clinical science (London, England : 1979)

Published: April 21, 2023

Complement C5 Protein as a Marker of Subclinical Atherosclerosis.

Complement C5 Protein as a Marker of Subclinical Atherosclerosis.

Journal: Journal of the American College of Cardiology

Published: December 23, 2019

Role of complement system in pathological remodeling of the vascular wall.

Role of complement system in pathological remodeling of the vascular wall.

Journal: Molecular immunology

Published: April 26, 2019

Lipocalin-2, a potential therapeutic target in advanced atherosclerosis.

Lipocalin-2, a potential therapeutic target in advanced atherosclerosis.

Journal: Atherosclerosis

Published: July 18, 2018

Arachidonic Acid, but Not Omega-3 Index, Relates to the Prevalence and Progression of Abdominal Aortic Aneurysm in a Population-Based Study of Danish Men.

Arachidonic Acid, but Not Omega-3 Index, Relates to the Prevalence and Progression of Abdominal Aortic Aneurysm in a Population-Based Study of Danish Men.

Journal: Journal of the American Heart Association

Published: January 28, 2018

Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.

Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.

Journal: International journal of molecular sciences

Published: October 04, 2017

Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development.

Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development.

Journal: Clinical science (London, England : 1979)

Published: June 16, 2017

Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression.

Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression.

Journal: Clinical science (London, England : 1979)

Published: January 08, 2016

Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.

Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.

Journal: Cardiovascular research

Published: November 16, 2015

Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.

Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.

Journal: Diabetes

Published: December 22, 2014

ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression.

ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression.

Journal: Thrombosis and haemostasis

Published: October 22, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026